Abstract:Background: Cardiomyocyte ischemia and hypoxia are important causes of oxidative stress damage and cardiomyocyte apoptosis in coronary heart disease (CHD). Epidemiological investigation has shown that eating more plant-based foods, such as vegetables and fruits, may significantly decrease the risk of CHD. As natural antioxidants, botanicals have fewer toxic side effects than chemical drugs and have great potential for development. Procyanidin B2 (PB2) is composed of flavan-3-ol and epicatechin and has been reported to have antioxidant and anti-inflammatory effects. However, whether PB2 exerts protective effects on hypoxic cardiomyocytes has remained unclear. This study aimed to explore the protective effect of PB2 against cardiomyocyte hypoxia and to provide new treatment strategies and ideas for myocardial ischemia and hypoxia in CHD. Methods and results: A hypoxic cardiomyocyte model was constructed, and a CCK-8 assay proved that PB2 had a protective effect on cardiomyocytes in a hypoxic environment. DCFH fluorescence staining, DHE staining, and BODIPY lipid oxidation assessment revealed that PB2 reduced the oxidative stress levels of cardiomyocytes under hypoxic conditions. TUNEL staining, Annexin V/PI fluorescence flow cytometry, and Western blot analysis of the expression of the apoptosis marker protein cleaved caspase-3 confirmed that PB2 reduced cardiomyocyte apoptosis under hypoxic conditions. JC-1 staining indicated that PB2 reduced the mitochondrial membrane potential of cardiomyocytes under hypoxia. In addition, transcriptomic analysis proved that the expression of 158 genes in cardiomyocytes was significantly changed after PB2 was added during hypoxia, of which 53 genes were upregulated and 105 genes were downregulated. GO enrichment analysis demonstrated that the activity of cytokines, extracellular matrix proteins and other molecules was changed significantly in the biological process category. KEGG enrichment analysis showed that the IL-17 signaling pathway and JAK-STAT signaling pathway underwent significant changes. We also performed metabolomic analysis and found that the levels of 51 metabolites were significantly changed after the addition of PB2 to cardiomyocytes during hypoxia. Among them, 39 metabolites exhibited increased levels, while 12 metabolites exhibited decreased levels. KEGG enrichment analysis showed that cysteine and methionine metabolism, arginine and proline metabolism and other metabolic pathways underwent remarkable changes. Conclusion: This study proves that PB2 can reduce the oxidative stress and apoptosis of cardiomyocytes during hypoxia to play a protective role. Transcriptomic and metabolomic analyses preliminarily revealed signaling pathways and metabolic pathways that are related to its protective mechanism. These findings lay a foundation for further research on the role of PB2 in the treatment of CHD and provide new ideas and new perspectives for research on PB2 in the treatment of other diseases.

Procyanidin B2 Ameliorates Endothelial Dysfunction Induced by Nicotine Via the Induction of Tetrahydrobiopterin Synthesis

Effects of Nicotine on the Number and Activity of Circulating Endothelial Progenitor Cells

Procyanidin B2 Attenuates Nicotine-Induced Hepatocyte Pyroptosis through a PPAR-Dependent Mechanism

Procyanidin B2 Attenuates Nicotine-Induced Hepatocyte Pyroptosis through a PPARγ-Dependent Mechanism

Procyanidin B2 Mitigates Endothelial Endoplasmic Reticulum Stress Through a PPARδ-Dependent Mechanism

Nicotine induces cyclooxygenase-2 and prostaglandin E(2) expression in human umbilical vein endothelial cells.

Nicotine induces endothelial dysfunction and promotes atherosclerosis via GTPCH1

Fenofibrate Improves Vascular Endothelial Function and Contractility in Diabetic Mice

Estradiol Pretreatment Attenuated Nicotine-Induced Endothelial Cell Apoptosis Via Estradiol Functional Membrane Receptor.

Procyanidin B2 Inhibits NLRP3 Inflammasome Activation in Human Vascular Endothelial Cells.

Procyanidin B2 alleviates oxidized low-density lipoprotein-induced cell injury, inflammation, monocyte chemotaxis, and oxidative stress by inhibiting the nuclear factor kappa-B pathway in human umbilical vein endothelial cells

Effects of a Dammarane-Type Saponin, Ginsenoside Rd, in Nicotine-Induced Vascular Endothelial Injury.

Nicotine-reduced endothelial progenitor cell senescence through augmentation of telomerase activity via the PI3K/Akt pathway

Chronic nicotine treatment enhances vascular smooth muscle relaxation in rats

Therapeutic effect of phycocyanin on chronic obstructive pulmonary disease in mice

PPARδ Agonist Prevents Endothelial Dysfunction Via Induction of Dihydrofolate Reductase Gene and Activation of Tetrahydrobiopterin Salvage Pathway

Nicotine Stimulates Adhesion Molecular Expression Via Calcium Influx and Mitogen-Activated Protein Kinases in Human Endothelial Cells

Protective effect and mechanism of procyanidin B2 against hypoxic injury of cardiomyocytes

Nicotine Induces Pro-inflammatory Response in Aortic Vascular Smooth Muscle Cells Through a NFκB/Osteopontin Amplification Loop-Dependent Pathway

Icariin Ameliorates Cigarette Smoke Induced Inflammatory Responses Via Suppression Of Nf-Kappa B And Modulation Of Gr In Vivo And In Vitro

DMSO-soluble smoking particles up-regulate the vascular endothelin receptors through AMPK-SIRT1 and MAPK pathways